Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|4|408-419

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.4, 2013-04, pp. : 408-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 7, 2011-09 ,pp. : 870-881

Bentham Science Publishers

Access to resources Recommend Favorite

Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 16-22

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 23-35

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 23-35

Bentham Science Publishers

Access to resources Recommend Favorite